Understand Your Medicine | By Mechanism Diligence

How does ibuprofen work (mechanism)?

Language

Change perspective

Explore the body

Adapted reference anatomy · schematic stomach

Translucent reference body with selected internal organs

Seek by sentence

Ready. Press Play to begin.

What brings you here? Optional

Established Visual: simplified teaching illustration

BEYOND THE STORY

Explore at your own pace.

Revisit the narration, understand the safety context, or follow the evidence.

01 The story in words

Read the full narration Choose any sentence to revisit it

Full narration

Scroll to read. Select a sentence to jump to that part.

02 Safety: what to know

Most adults can use ibuprofen, but it is not suitable for everyone. Common side effects include indigestion, stomach upset and nausea; not everyone gets them.

Serious effects are less common, but can include stomach or intestinal bleeding, kidney problems, heart attack, stroke and severe allergic reactions. Risk varies with dose, duration, health conditions and other medicines. Higher doses or longer use can increase risk. Follow your product label and use the smallest effective dose for the shortest time needed. Ask a pharmacist or clinician if you are unsure it suits you, especially with other medicines, a history of ulcers, heart or kidney disease, or pregnancy.

When to get help: stop taking it and seek urgent medical help for vomiting blood, black stools, chest pain, trouble breathing, facial or throat swelling, sudden weakness or slurred speech. Ask a pharmacist or clinician about side effects that persist or bother you.

NHS: suitability and side effects · US 200 mg OTC label: full warnings · Full patient information

Study risk numbers & comparison limits

What do the percentages show?

There is no reliable overall mild / moderate / severe split for everyone who takes ibuprofen. These are results from specific studies, not your personal odds.

Reported symptom intensity · PAIN trial, 1999

Adults aged 18–75 with short-term pain; ibuprofen up to 1,200 mg/day for 1–7 days, compared with paracetamol up to 3,000 mg/day. Follow-up calls: days 7–9. People with contraindications were excluded.

Participants reporting events; percentages rounded as published
Intensity	Ibuprofen 2,869 people	Paracetamol 2,874 people
Mild	Not separately reported	Not separately reported
Moderate	8.5% 245 / 2,869	10.2% 294 / 2,874
Severe	3.5% 100 / 2,869	3.2% 92 / 2,874

Moderate meant interference with daily activities; severe meant activities were impossible. Severity is different from medical seriousness. Reports do not establish that the medicine caused an event. Categories are not a complete, mutually exclusive breakdown: do not add them or subtract them to calculate “mild.” No placebo group was included. This short study cannot reliably quantify rare serious harm or longer-term risk.

PAIN study: methods and Table II, pages 90–94 · Industry-funded study.

A separate placebo comparison · digestive symptoms

In a 1999 trial of healthy participants taking 1,200 mg/day for 10 days, digestive events were reported by 19% (161 / 833) on ibuprofen and 16% (67 / 413) on placebo. Examples included indigestion, abdominal pain and nausea. These are reported events of any intensity, not percentages proven to be caused by ibuprofen, and not “mild” or “severe” rates. The authors reported similar rates; this does not prove equal safety. Results do not describe high-dose prescription or long-term use, and do not mean zero serious risk. Doyle et al., 1999: study abstract.

Timing: this example covers standard immediate-release ibuprofen taken by mouth. Pain relief may begin in about 30–60 minutes; the person, food and formulation can change timing. This is onset of relief, not peak blood concentration or a dosing interval. Oral pain-relief timing source.

This is a brief overview, not all warnings or personal treatment advice.

03 Go a little deeper

Anatomy controls & organs

Layers & camera

Skin opacity Reference organs Teaching overlays Camera follows the story

The close-up is schematic. Shapes, scale, particle counts and motion do not represent measured protein geometry, concentrations or timing.

Preparing anatomy…

Why this schedule? · standard oral 200 mg tablet

This example uses a US over-the-counter label for standard immediate-release 200 mg ibuprofen tablets, for adults and children aged 12 and over. Its directions specify a 4–6 hour interval while symptoms persist, with product-specific daily limits. Follow your own product label or prescription; this explanation does not set your dose.

Conceptual sequence, not a measured concentration curve. Peak blood level, onset of relief and how long relief lasts are different quantities. These figures do not apply to modified-release tablets or other routes.

Exact OTC label: directions · Pharmacokinetic evidence · Oral relief timing

Explore ten questions for your perspective

Check your understanding · optional

Does ibuprofen act only where it hurts? Yes, only there No, it can affect other parts of the body

If pain eases, does that prove its cause is fixed? Yes No

No score or answers are sent or saved.

04 Evidence & transparency

Educational draft · independent clinical review pending.

Our priority is a reviewed visual library with measured evidence of better understanding. No learning benefit has been established yet. See the proposed evaluation and review steps.

English patient story: evidence and visual limits ↗ · All ten scripts and source review ↗ · Research by perspective ↗

About the visuals & narration

Conceptual diagrams; shapes, scale and timing are simplified. Synthetic narration, not a clinician recording. Voice quality varies by device and may use its speech service. No microphone is needed. Resume repeats the current caption to keep sound and scenes together. Mute uses timed captions. If voice is unavailable, caption playback remains available.

Scientific review record · draft, unreviewed

No independent clinical or scientific reviewer has approved this prototype. No reviewer identity, credentials or review outcome is asserted.

Scope: Ibuprofen, standard immediate-release oral example; mechanism, timing, safety, audience scripts and optional answers.
Content status: AI-assisted educational draft. Source checks are not clinical validation.
Sources checked: September 26–30, 2026. Source links appear with captions, answers and numerical claims.
Reviewers and approvals: None recorded. Human review and permission to name the reviewer are still required.

Established marks source-supported clinical or pharmacological statements. Simplified marks teaching models. Proposed experiments are labeled as proposals, not findings. An unanswered question is explicitly marked unavailable.

Download the review record

Manual anatomy exploration is available under Explore below. Drug, tissue and enzyme shapes are schematic; they do not show measured drug concentrations, binding geometry or selective targeting.

What medicine or drug mechanism are you interested in?